Fortis Malar [FORTISMLR] vs Max Healthcare [MAXHEALTH] Detailed Stock Comparison

Fortis Malar

BSE
Loading...

Max Healthcare

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Fortis Malar wins in 9 metrics, Max Healthcare wins in 10 metrics, with 0 ties. Max Healthcare appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricFortis MalarMax HealthcareBetter
P/E Ratio (TTM)26.3690.92Fortis Malar
Price-to-Book Ratio4.0211.08Fortis Malar
Debt-to-Equity Ratio0.0032.09Fortis Malar
PEG Ratio0.002.99Fortis Malar
EV/EBITDA154.2954.13Max Healthcare
Profit Margin (TTM)22,483.90%15.27%Fortis Malar
Operating Margin (TTM)-1,572.20%20.65%Max Healthcare
EBITDA Margin (TTM)N/A20.65%N/A
Return on Equity1.30%11.47%Max Healthcare
Return on Assets (TTM)1.06%7.07%Max Healthcare
Free Cash Flow (TTM)$15.44M$4.94BMax Healthcare
Dividend Yield3.38%0.23%Fortis Malar
1-Year Return28.02%21.27%Fortis Malar
Price-to-Sales Ratio (TTM)5,928.8013.84Max Healthcare
Enterprise Value$893.16M$1,062.90BMax Healthcare
EV/Revenue Ratio4,356.8814.15Max Healthcare
Gross Profit Margin (TTM)100.00%78.04%Fortis Malar
Revenue per Share (TTM)$0$77Max Healthcare
Earnings per Share (Diluted)$2.46$11.76Max Healthcare
Beta (Stock Volatility)-0.100.21Fortis Malar
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Fortis Malar vs Max Healthcare Stock Performance Analysis

Loading Price Chart...

Fortis Malar
Max Healthcare
Fortis Malar Stock Overview | Max Healthcare Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Fortis Malar12.88%13.38%6.95%2.06%-4.30%18.75%
Max Healthcare6.59%2.49%-0.86%-12.30%5.97%0.01%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Fortis Malar28.02%30.02%52.82%60.70%103.62%520.34%
Max Healthcare21.27%166.44%954.30%919.87%919.87%919.87%

News Based Sentiment: Fortis Malar vs Max Healthcare

Fortis Malar

News based Sentiment: MIXED

October brought a mix of developments for Fortis Malar, with a key regulatory approval for a potential ownership change alongside improving, but still negative, financial results. The insider trading activity adds a layer of intrigue, suggesting someone believes in the company's future, but the overall picture remains complex.

View Fortis Malar News Sentiment Analysis

Max Healthcare

News based Sentiment: MIXED

The month showcased a clear contrast between strong financial performance and concerning trading activity. While the company reported impressive Q4 and FY25 results, the stock underperformed, experienced significant institutional selling, and saw a surge in open interest, creating a mixed investment narrative.

View Max Healthcare News Sentiment Analysis

Performance & Financial Health Analysis: Fortis Malar vs Max Healthcare

MetricFORTISMLRMAXHEALTH
Market Information
Market Cap i₹1.22B₹1.12T
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i13,8918,172,910
90 Day Avg. Volume i15,9574,476,374
Last Close₹73.20₹1,139.70
52 Week Range₹55.15 - ₹98.70₹888.90 - ₹1,314.30
% from 52W High-25.84%-13.28%
All-Time High₹107.94 (Apr 22, 2024)₹1,314.30 (Jul 04, 2025)
% from All-Time High-32.18%-13.28%
Growth Metrics
Quarterly Revenue GrowthN/A0.31%
Quarterly Earnings GrowthN/A0.30%
Financial Health
Profit Margin (TTM) i224.84%0.15%
Operating Margin (TTM) i-15.72%0.21%
Return on Equity (TTM) i0.01%0.11%
Debt to Equity (MRQ) i0.0032.09
Cash & Liquidity
Book Value per Share (MRQ)₹16.12₹96.50
Cash per Share (MRQ)₹17.19₹6.81
Operating Cash Flow (TTM) i₹-10,605,000₹13.02B
Levered Free Cash Flow (TTM) i₹3.92M₹10.76B
Dividends
Last 12-Month Dividend Yield i3.38%0.23%
Last 12-Month Dividend i₹2.50₹3.00

Valuation & Enterprise Metrics Analysis: Fortis Malar vs Max Healthcare

MetricFORTISMLRMAXHEALTH
Price Ratios
P/E Ratio (TTM) i26.3690.92
Forward P/E iN/A49.24
PEG Ratio i0.002.99
Price to Sales (TTM) i5,928.8013.84
Price to Book (MRQ) i4.0211.08
Market Capitalization
Market Capitalization i₹1.22B₹1.12T
Enterprise Value i₹893.16M₹1.06T
Enterprise Value Metrics
Enterprise to Revenue i4,356.8814.15
Enterprise to EBITDA i154.2954.13
Risk & Other Metrics
Beta i-0.100.21
Book Value per Share (MRQ) i₹16.12₹96.50

Financial Statements Comparison: Fortis Malar vs Max Healthcare

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)FORTISMLRMAXHEALTH
Revenue/Sales i₹205,000₹20.28B
Cost of Goods Sold i₹0₹4.45B
Gross Profit i₹205,000₹15.82B
Research & Development iN/AN/A
Operating Income (EBIT) i₹42.85M₹4.19B
EBITDA i₹42.85M₹5.59B
Pre-Tax Income i₹42.85M₹4.00B
Income Tax i₹1.32M₹924.60M
Net Income (Profit) i₹41.53M₹3.08B

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)FORTISMLRMAXHEALTH
Cash & Equivalents i₹2.02M₹6.62B
Total Current Assets i₹341.12M₹15.93B
Total Current Liabilities i₹66.23M₹18.14B
Long-Term Debt iN/A₹27.68B
Total Shareholders Equity i₹302.09M₹93.81B
Retained Earnings i₹18.80M₹31.11B
Property, Plant & Equipment i₹0₹19.32B

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)FORTISMLRMAXHEALTH
Operating Cash Flow iN/AN/A
Capital Expenditures iN/AN/A
Free Cash Flow iN/AN/A
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricFORTISMLRMAXHEALTH
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Average Daily Volume (10 Day) i13,8918,172,910
Average Daily Volume (90 Day) i15,9574,476,374
Shares Outstanding i18.74M972.14M
Float Shares i4.83M683.01M
% Held by Insiders i0.72%0.24%
% Held by Institutions i0.00%0.47%

Dividend Analysis & Yield Comparison: Fortis Malar vs Max Healthcare

MetricFORTISMLRMAXHEALTH
Last 12-Month Dividend i₹2.50₹3.00
Last 12-Month Dividend Yield i3.38%0.23%
3-Year Avg Annual Dividend i₹14.17₹1.33
3-Year Avg Dividend Yield i26.20%0.15%
3-Year Total Dividends i₹42.50₹4.00
Ex-Dividend DateJul 24, 2024Jul 04, 2025